Table 3.
Comparisons of outcomes and durations between survivors and non-survivors or different risk group in patients with severe COVID-19.
| Characteristics | Patients (n=113) No. (%) or Median (rang) | Presence of severe |
P | Hazard subgroup |
P | ||
|---|---|---|---|---|---|---|---|
| Survivors (n=64) No. (%) or Median (rang) | Non-survivors (n=49) No. (%) or Median (rang) | Low risk (n=60) No. (%) or Median (rang) | High risk (n=53) No. (%) or Median (rang) | ||||
| Complications-n (%) | |||||||
| Sepsis | 9(8·0) | 0 | 9(18·4) | 0·001 | 3(5·0) | 6(11·3) | 0·373 |
| Respiratory failure | 47(41·6) | 7(10·9) | 40(81·6) | <0·001 | 6(10·0) | 41(77·4) | <0·001 |
| Acute myocardial injury | 44(38·9) | 7(10·9) | 37(75·5) | <0·001 | 8(13·3) | 36(67·9) | <0·001 |
| Acute kidney injury | 26(23·0) | 6(9·4) | 20(40·8) | <0·001 | 6(10·0) | 20(37·7) | <0·001 |
| Acute liver injury | 29(25·7) | 8(12·5) | 21(42·9) | <0·001 | 9(15·0) | 20(37·7) | 0·006 |
| Acidosis | 21(18·6) | 0 | 21(42·9) | <0·001 | 3(5·0) | 18(34·0) | <0·001 |
| Secondary infection | 19(16·8) | 6(9·4) | 13(26·5) | 0·016 | 5(8·3) | 14(26·4) | 0·010 |
| Coagulopathy | 21(18·6) | 4(6·3) | 17(34·7) | <0·001 | 7(11·7) | 14(26·4) | 0·044 |
| Durations-median (rang) | |||||||
| Time from illness onset to admission | 7·0(0–41·0) | 7·0(1·0–41·0) | 8·0(0–30·0) | 0·958 | 7·0(1·0–41·0) | 8·0(0–30·0) | 0·411 |
| Time from illness onset to death or discharge | 26·0(2·0–67·0) | 30·0(11·0–67·0) | 21·0(2·0–54·0) | <0·001 | 30·0(11·0–67·0) | 22·0(2·0–52·0) | 0·005 |
| Time from illness onset to sepsis | 22·0(8·0–31·0) | NA | 22·0(8·0–31·0) | – | 25·0(22·0–31·0) | 21·5(8·0–28·0) | 0·262 |
| Time from illness onset to respiratory failure | 11·0(2·0–35·0) | 12·0(8·0–33·0) | 10·0(2·0–35·0) | 0·256 | 14·0(11·0–33·0) | 10·0(2·0–35·0) | 0·056 |
| Time from illness onset to acute myocardial injury | 14·5(2·0–34·0) | 14·0(7·0–25·0) | 15·0(2·0–34·0) | 0·950 | 17·0(8·0–26·0) | 13·5(2·0–34·0) | 0·247 |
| Time from illness onset to acute kidney injury | 16·5(2·0–52·0) | 11·5(2·0–52·0) | 17·0(2·0–37·0) | 0·355 | 16·5(2·0–52·0) | 16·5(2·0–37·0) | 0·929 |
| Time from illness onset to acute liver injury | 16·0(2·0–39·0) | 13·0(4·0–31·0) | 17·0(2·0–39·0) | 0·301 | 17·0(4·0–31·0) | 12·0(2·0–39·0) | 0·871 |
| Time from illness onset to acidosis | 19·0(5·0–35·0) | NA | 19·0(5·0–35·0) | – | 18·0(17·0–20·0) | 19·0(5·0–35·0) | 0·814 |
| Time from illness onset to secondary infection | 13·0(4·0–25·0) | 12·0(4·0–25·0) | 13·0(4·0–25·0) | 0·701 | 10·0(4·0–25·0) | 14·5(4·0–25·0) | 0·500 |
| Time from illness onset to coagulopathy | 19·0(4·0–41·0) | 14·5(11·0–22·0) | 20·0(4·0–41·0) | 0·144 | 17·0(11·0–27·0) | 20·5(4·0–41·0) | 0·322 |